Tag

Skin of Color Update

GLP-1 Agonists & Psoriasis Comorbidities

By Video Pearls

GLP-1 agonists

Psoriasis is more than skin deep—it is a systemic inflammatory condition. Jennifer Soung, MD, FAAD, argues that addressing metabolic health is no longer outside the scope of dermatology; it is essential for clinical success.

In a Next Steps in Derm video interview at our sister conference Skin of Color Update, Dr. Soung dives into:

  • The Weight-Biologic Link: How excess weight directly impacts the efficacy of biologic therapies.
  • GLP-1 Agonists: Incorporating modern weight management tools into the psoriatic care plan.
  • The Patient Conversation: Strategies for broaching the sensitive topic of weight with empathy and clinical precision.
  • Comorbidity Management: A comprehensive look at tackling psoriatic arthritis and metabolic syndrome.

Stop treating the skin in a vacuum. Learn how to optimize your patients’ systemic health for better dermatologic outcomes.

Psoriasis and Psoriatic Arthritis in Patients With Skin of Color

By Video Pearls

psoriasis and psoriatic arthritis in patients with skin of color

In a video interview at our sister conference, Skin of Color Update, Mona Shahriari, MD, FAAD, encouraged dermatology clinicians to broaden the psoriasis color palette. She says recognizing the skin tone differences in the presentation of psoriasis can improve diagnosis and care. Dr. Shahriari is associate clinical professor of dermatology at Yale University School of Medicine.

Watch as she shares:

  • The role of biopsy when diagnosing psoriasis in skin of color
  • Challenges in diagnosing psoriatic arthritis in patients with darker skin tones
  • Latest research in treating scalp psoriasis
  • Pigmentary sequelae and the quality of life impact

If you’re committed to providing quality psoriasis care for all of your patients, this is a must-view video.